What should I do if I missed two doses of ZyTiga (abiraterone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What to Do If You Missed Two Doses of ZyTiga (Abiraterone)

Do not double up or take extra doses to make up for the two missed doses—simply resume your regular dosing schedule with the next scheduled dose.

Immediate Action

When you realize you've missed two doses of abiraterone:

  • Take your next dose at the regularly scheduled time
  • Do not attempt to "catch up" by taking multiple doses at once
  • Do not take extra doses over the following days

The principle here is straightforward: abiraterone has a relatively long half-life in the context of prostate cancer treatment, and the drug accumulates to steady-state levels over time. Taking double or triple doses creates unnecessary risk of adverse events without meaningful clinical benefit.

Why Not Double Up?

While some theoretical pharmacokinetic models suggest doubling doses after missed doses might be appropriate for drugs with long half-lives 1, this approach is not recommended for abiraterone because:

  • Abiraterone has significant dose-dependent toxicities, particularly hypertension, cardiac disorders, and hepatotoxicity, which occurred in 10% and 7% of patients respectively in clinical trials 2
  • The drug requires careful monitoring of blood pressure and hepatic function 2
  • Grade 3-5 adverse events are already substantial at standard dosing (47% in patients ≥70 years) 2

Clinical Context

Missing two doses in the context of metastatic castration-sensitive prostate cancer (mCSPC) or metastatic castration-resistant prostate cancer (mCRPC) treatment is concerning but not catastrophic:

  • Abiraterone is typically given continuously for months to years 2, 3
  • The drug works by sustained androgen suppression, not by achieving specific peak concentrations
  • Two missed doses represent a small fraction of the total treatment duration
  • The combination with ADT (androgen deprivation therapy) provides ongoing disease control even during the brief interruption

Important Follow-Up Steps

After resuming your regular schedule:

  • Contact your oncology team to inform them of the missed doses
  • Ensure you understand your dosing schedule going forward
  • Consider setting up reminders (phone alarms, pill organizers) to prevent future missed doses 4
  • Do not skip your next monitoring appointments for blood pressure, liver function, and PSA levels

Common Pitfall to Avoid

The most dangerous response would be taking multiple doses at once to "make up" for missed doses. This significantly increases your risk of:

  • Severe hypertension
  • Cardiac events
  • Hepatotoxicity
  • Other grade 3-5 adverse events

These risks far outweigh any theoretical benefit from attempting to restore drug levels more quickly.

References

Research

What should patients do if they miss a dose of medication? A theoretical approach.

Journal of pharmacokinetics and pharmacodynamics, 2021

Guideline

prostate cancer, version 3.2026, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2025

Research

Educating patients about missed medication doses.

Journal of psychosocial nursing and mental health services, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.